SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

Figure 6

In gastric cancer, SFRP4 is an independent prognostic factor, and SFRP4 paired with CD8⁺T cells can better predict prognosis. (a) Kaplan-Meier survival curves for OS in tumor tissues based on SFRP4 expression. (b) Kaplan-Meier survival curves for OS based on tumor tissue PD-L1 expression. (c) Kaplan-Meier survival curves for OS in tumor tissues based on CD3+ T-cell expression. (d) Kaplan-Meier survival curves for OS in tumor tissues based on CD4+ T-cell expression. (e) Kaplan-Meier survival curves for OS in tumor tissues based on CD8+ T-cell expression. (f) Kaplan-Meier survival curves for OS based on SFRP4 expression in tumor tissues in combination with CD8⁺T expression.

(a)

(b)

(c)

(d)

(e)

(f)